Case Studies
Every engagement is measured by the impact it delivers. These are the results.
AI Strategy for Fortune 500 HealthCareCo
Evaluated 50+ AI use cases, built an ML model with 90%+ accuracy as a quick win, and designed a portfolio of pilots that got CEO buy-in.
Fortune 500 Healthcare Acquisition
Directed due diligence and Day 1/100 integration for a ~$300M acquisition. Cross-functional synergy identification and financial modeling.
Healthcare Federal Contractor Growth Strategy
Rebuilt growth strategy using federal procurement data and probabilistic financial modeling. Dynamic model incorporating win probabilities and resource constraints.
Mid-Market PharmaCo Exit Strategy
Identified optimal acquirers across four segments, positioned US manufacturing license as core value driver, created competitive three-way bidding process.
FinTechCo ML Value Investing Model
Built ML-driven value investing model using CatBoost across ~2,600 stocks with 20 years of data. Automated 13F analysis with LLM-powered recommendations.
Defensive Growth Roadmap for Open Source TechCo
Built defensive strategy for a top-5 global open source company facing LLM-driven search revenue declines. Modeled impact and designed offsetting revenue streams.
AI and Crypto Hyperscaler Blueprint
Analyzed 20+ global jurisdictions for data center positioning. Built dual-use infrastructure framework enabling crypto-to-AI transition.
Solar O&M Middle East Go-to-Market
Devised Middle East entry plan leveraging IoT monitoring technology as core value proposition with strategic regional partnerships.
SaaS Proposal Development Platform
Built end-to-end business model focusing on consulting services vertical. LLM-powered software with LinkedIn-focused go-to-market.
Sharing Economy Insurance Startup
Served as consulting CEO. Built risk framework, structured reinsurer partnerships, achieved product-market fit. Recognized by Startup Bootcamp UK and MWC.
Luxury Spirits DTC Business Model
Served as consulting CEO. Navigated three-tier regulations, built digital acquisition strategy. 75% fulfillment reduction, 30% CAC reduction, 20% margin increase.
Fortune 500 Pharma FP&A Transformation
Designed enterprise FP&A process integrating project, resource, and CAPEX planning. Reduced company-wide FP&A time by ~50%.
Fortune 500 PharmaCo Direct Marketing
Deep analysis of provider prescription data to determine highest-yielding engagement channels. Built comprehensive playbook for speaker programs.
LATAM Market Entry for $1B+ PeripheralsCo
Built market entry strategy through targeted product distribution, localized pricing, and geo-specific marketing. Genuine localization over lift-and-shift.